Manulife (Manufacturers Life Insurance)
MRKR icon

Manulife (Manufacturers Life Insurance)’s Marker Therapeutics MRKR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,760
Closed -$51K – 2871
2019
Q4 		$51K Sell
1,760
-146
-8% -$5.31K ﹤0.01% 2848
2019
Q3 		$100K Buy
1,906
+15
+0.8% +$886 ﹤0.01% 2819
2019
Q2 		$150K Buy
+1,891
New +$112K ﹤0.01% 2778

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VWM
Vigilare Wealth Management Scottsdale, Arizona $326M AUM 21.58% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s MRKR Position: Q1 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Marker Therapeutics (MRKR) in Q1 2020, closing a stake of 1,760 shares — an estimated $51K sold.

Manulife (Manufacturers Life Insurance) first reported a position in MRKR in Q2 2019 and held it in 3 quarters. The position peaked at $150K in Q2 2019. 65 funds tracked by Wall St. Rank hold MRKR as of Q1 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Marker Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,760 Marker Therapeutics shares in Q1 2020, an estimated $51K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Marker Therapeutics in Q2 2019 and held it in 3 quarters.
  • Manulife (Manufacturers Life Insurance)'s Marker Therapeutics position peaked at $150K in Q2 2019.
  • 65 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2020, filed 15 May 2020.